US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vectren

72.38

0.0000

Volume:- -

Turnover:- -

Market Cap:6.01B

PE:30.51

High:72.38

Open:72.38

Low:72.38

Close:72.38

52wk High:72.40

52wk Low:58.00

Shares:83.08M

Float Shares:82.95M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.37

EPS(LYR):2.60

ROE:--

ROA:--

PB:3.21

PE(LYR):27.81

Loading ...

Overview Company News Filings

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK

VVC Resources Exits Gloria Copper Project to Focus on Promising Gold and Gas Ventures

Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections

CenterPoint Energy to Sell Vectren Energy Delivery to National Fuel Gas for $2.62 Billion

MT Newswires Live

SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)

VVC Resources Launches Central Kansas Uplift Helium Project

VVC Exploration Secures Chairman’s Loan and Announces Director Resignation

SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)

SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025

SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VVC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVC\",,,,,undefined,":{"symbol":"VVC","market":"US","secType":"STK","nameCN":"Vectren","latestPrice":72.38,"timestamp":1575925200000,"preClose":72.38,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":82950092,"shares":83080695,"eps":2.372554,"marketStatus":"Delisted","change":0,"latestTime":"12-09 16:00:00 EST","open":72.38,"high":72.38,"low":72.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.372554,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":72.38,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVC\",,,,,undefined,":{"symbol":"VVC","floatShares":82950092,"roa":"--","roe":"--","lyrEps":2.602409,"shares":83080695,"dividePrice":0,"high":72.38,"amplitude":0,"preClose":72.38,"low":72.38,"week52Low":58,"pbRate":"3.21","week52High":72.4,"institutionHeld":0.5729,"latestPrice":72.38,"eps":2.372554,"divideRate":0,"volume":0,"delay":0,"ttmEps":2.372554,"open":72.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-14","symbol":"VVC","amount":0.48,"name":"埃文斯威市电力","currency":"USD","type":"dividend","dateTimestamp":1542171600000},{"market":"US","date":"2018-11-05","symbol":"VVC","fiscalQuarterEnding":"2018/09","expectedEps":0.75,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1541394000000,"reportTimeType":"post","actualEps":0.71},{"market":"US","date":"2018-08-14","symbol":"VVC","amount":0.45,"name":"埃文斯威市电力","currency":"USD","type":"dividend","dateTimestamp":1534219200000},{"market":"US","date":"2018-08-01","symbol":"VVC","fiscalQuarterEnding":"2018/06","expectedEps":0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1533096000000,"reportTimeType":"post","actualEps":0.56},{"market":"US","date":"2018-05-14","symbol":"VVC","amount":0.45,"name":"埃文斯威市电力","currency":"USD","type":"dividend","dateTimestamp":1526270400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VVC\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-13","recordDate":null,"paymentDate":null,"value":0.42,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":null,"paymentDate":null,"value":0.42,"currency":"USD"},{"executeDate":"2017-08-11","recordDate":null,"paymentDate":null,"value":0.42,"currency":"USD"},{"executeDate":"2017-11-14","recordDate":null,"paymentDate":null,"value":0.45,"currency":"USD"},{"executeDate":"2018-02-14","recordDate":null,"paymentDate":null,"value":0.45,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VVC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VVC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606671906","title":"SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606671906","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606671906?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:00","pubTimestamp":1769605200,"startTime":"0","endTime":"0","summary":"This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J., Jan.  28, 2026  (G","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227560/0/en/SCYNEXIS-Announces-Presentations-Highlighting-the-Potent-Antifungal-Activity-of-its-Second-Generation-Fungerp-SCY-247-Against-Drug-Resistant-Fungi-at-the-Inaugural-Interdisciplinar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4188","VVC","IDSA","SCY","SCYX","BK4007","ASM"],"gpt_icon":0},{"id":"2584161945","title":"SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2584161945","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584161945?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553600,"startTime":"0","endTime":"0","summary":"GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190785/0/en/SCYNEXIS-Completes-Transfer-of-BREXAFEMME-New-Drug-Application-to-GSK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","LU1829250122.USD","BK4585","VVC","BK4588","BK4532","BK4007","GSK.UK","GSK"],"gpt_icon":0},{"id":"2584963532","title":"VVC Resources Exits Gloria Copper Project to Focus on Promising Gold and Gas Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2584963532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584963532?lang=en_us&edition=fundamental","pubTime":"2025-11-19 04:07","pubTimestamp":1763496443,"startTime":"0","endTime":"0","summary":"The latest announcement is out from VVC Exploration ( ($TSE:VVC) ). VVC Resources has decided to exit the Gloria Copper Project in Mexico due to hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vvc-resources-exits-gloria-copper-project-to-focus-on-promising-gold-and-gas-ventures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vvc-resources-exits-gloria-copper-project-to-focus-on-promising-gold-and-gas-ventures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MHGmain","VVC","1OZmain","HGmain","QCmain"],"gpt_icon":0},{"id":"2584622145","title":"Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2584622145","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584622145?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:15","pubTimestamp":1763392500,"startTime":"0","endTime":"0","summary":"Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat resistant fungal infections, including the Company’s next gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3189320/0/en/Scynexis-Announces-Federal-Funding-of-Collaboration-Between-Hackensack-Meridian-CDI-and-Johns-Hopkins-Researchers-to-Develop-New-Therapeutics-Including-Novel-Fungerps-for-Resistant.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4585","AMR","BK4006","EBSB","VVC","BK4588","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2577382933","title":"CenterPoint Energy to Sell Vectren Energy Delivery to National Fuel Gas for $2.62 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2577382933","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577382933?lang=en_us&edition=fundamental","pubTime":"2025-10-21 18:37","pubTimestamp":1761043070,"startTime":"0","endTime":"0","summary":"CenterPoint Energy to Sell Vectren Energy Delivery to National Fuel Gas for $2.62 Billion","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4208","NFG","CNP","BK4585","BK4588","IE00BD4GTW91.USD","IE00BD4GTV84.USD","LU2380233275.USD","IE00BD4GTT62.SGD","BK4197","VVC"],"gpt_icon":0},{"id":"2571347882","title":"SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)","url":"https://stock-news.laohu8.com/highlight/detail?id=2571347882","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571347882?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:00","pubTimestamp":1759233600,"startTime":"0","endTime":"0","summary":"No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our first-generation fungerp Safety, tolerability, and pharmacokinetic profile ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/30/3158537/0/en/SCYNEXIS-Announces-Positive-Results-from-a-Phase-1-Single-Ascending-Dose-and-Multiple-Ascending-Dose-Study-of-its-Second-Generation-Fungerp-SCY-247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCY","VVC","BK4007","SCYX"],"gpt_icon":0},{"id":"2571856396","title":"VVC Resources Launches Central Kansas Uplift Helium Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2571856396","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571856396?lang=en_us&edition=fundamental","pubTime":"2025-09-30 10:02","pubTimestamp":1759197768,"startTime":"0","endTime":"0","summary":"VVC Exploration ( ($TSE:VVC) ) has issued an announcement. VVC Resources has announced the strategic development of its Central Kansas Uplift Proje...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vvc-resources-launches-central-kansas-uplift-helium-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vvc-resources-launches-central-kansas-uplift-helium-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VVC"],"gpt_icon":0},{"id":"2568479704","title":"VVC Exploration Secures Chairman’s Loan and Announces Director Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2568479704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568479704?lang=en_us&edition=fundamental","pubTime":"2025-09-18 11:03","pubTimestamp":1758164637,"startTime":"0","endTime":"0","summary":"VVC Exploration ( ($TSE:VVC) ) has shared an update. VVC Exploration Corporation announced a US$700,000 loan from its Chairman, Terrence Martell, t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vvc-exploration-secures-chairmans-loan-and-announces-director-resignation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vvc-exploration-secures-chairmans-loan-and-announces-director-resignation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VVC"],"gpt_icon":0},{"id":"2564374002","title":"SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374002","media":"GlobeNewswire","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374002?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:30","pubTimestamp":1756989000,"startTime":"0","endTime":"0","summary":"Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistanceAdditional poste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144512/0/en/SCYNEXIS-Announces-Multiple-Presentations-Highlighting-Data-from-its-Second-Generation-Fungerp-SCY-247-at-the-12th-Congress-on-Trends-in-Medical-Mycology-TIMM-12.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SCY","VVC","CET","SCYX"],"gpt_icon":0},{"id":"2562497302","title":"SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2562497302","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562497302?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:00","pubTimestamp":1756123200,"startTime":"0","endTime":"0","summary":"JERSEY CITY, N.J., Aug.  25, 2025  (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resist","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/25/3138396/0/en/SCYNEXIS-to-Participate-in-the-H-C-Wainwright-27th-Annual-Global-Conference-September-8-10-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVC","BK4007","SCYX"],"gpt_icon":0},{"id":"2559170981","title":"SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2559170981","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559170981?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:30","pubTimestamp":1755117000,"startTime":"0","endTime":"0","summary":"First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3133017/0/en/SCYNEXIS-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU0267386448.USD","LU1363072403.SGD","LU2746668974.SGD","VVC","LU2746668461.USD","SCYX","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","IE00BHPRN162.USD","IE00BZ1G4Q59.USD","IE00BFXG1179.USD","BK4006","LU0882574139.USD","LU0971096721.USD","CMC","LU0149725797.USD","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}